Ritter Reaction Mediated by Bismuth(III) Salts: One-Step Conversion of ­Epoxides into vic-Acylamino-Hydroxy Compounds

Rui M. A. Pinto; Jorge A. R. Salvador; Christophe Le Roux

doi:10.1055/s-2006-949608

LETTER

Ritter Reaction Mediated by Bismuth(III) Salts: One-Step Conversion of Epoxides into vic-Acylamino-Hydroxy Compounds

Rui M. A. Pinto^a, Jorge A. R. Salvador*^a, Christophe Le Roux^b
^a Laboratório de Química Farmacêutica, Faculdade de Farmácia, Universidade de Coimbra, 3000-295, Coimbra, Portugal
Fax: +351(239)827126; e-Mail: salvador@ci.uc.pt;
^b Laboratoire Hétérochimie Fondamentale et Appliquée, 118, Route de Narbonne, 31062 Toulouse Cedex 9, France

Abstract

Alle Artikel dieser Rubrik

Abstract

Bismuth salts promote a new one-step conversion of epoxides into vic-acylamino-hydroxy compounds in very high yields.

Key words

bismuth salts - epoxides - steroids - ring opening - vic-acylamino-hydroxy compounds

Volltext

Referenzen

References and Notes

<A NAME="RG14106ST-1">1</A> Ritter JJ. Minieri PP. J. Am. Chem. Soc. 1948, 70: 4045

<A NAME="RG14106ST-2A">2a</A> Zil’Berman EN. Russ. Chem. Rev. 1960, 29: 331

<A NAME="RG14106ST-2B">2b</A> Krimen LI. Cota DJ. Org. React. 1969, 17: 213

<A NAME="RG14106ST-3">3</A> Ritter JJ. Kalish J. J. Am. Chem. Soc. 1948, 70: 4048

<A NAME="RG14106ST-4">4</A> Benson FR. Ritter JJ. J. Am. Chem. Soc. 1949, 71: 4128

<A NAME="RG14106ST-5A">5a</A> Hathaway BA. J. Chem. Educ. 1989, 66: 776

<A NAME="RG14106ST-5B">5b</A> Colombo MI. Bohn ML. Rúveda EA. J. Chem. Educ. 2002, 79: 484

<A NAME="RG14106ST-6">6</A> Smith JRL. Norman ROC. Stillings MR. J. Chem. Soc., Perkin Trans. 1 1975, 1200

<A NAME="RG14106ST-7">7</A> Ducker JW. Lazer SC. Aust. J. Chem. 1970, 23: 2535

<A NAME="RG14106ST-8">8</A> Teutsch G. Shapiro EL. Herzog HL. J. Med. Chem. 1970, 13: 750

<A NAME="RG14106ST-9">9</A> Bourgery G. Frankel JJ. Julia S. Ryan RJ. Tetrahedron 1972, 28: 1377

<A NAME="RG14106ST-10">10</A> Ryan RJ. Julia S. Tetrahedron 1973, 29: 3649

<A NAME="RG14106ST-11">11</A> Narayanan CR. Kulkarni AK. Landage AB. Wadia MS. Indian J. Chem. 1974, 12: 992

<A NAME="RG14106ST-12">12</A> Narayanan CR. Kulkarni AK. Landge AB. Wadia MS. Synthesis 1977, 35

<A NAME="RG14106ST-13A">13a</A> Sun H. Li H. Sadler PJ. Chem. Ber. Recl. 1997, 130: 669

<A NAME="RG14106ST-13B">13b</A> Briand GG. Burford N. Chem. Rev. 1999, 99: 2601

<A NAME="RG14106ST-14">14</A> Tiekink ERT. Crit. Rev. Oncol./Hematol. 2002, 42: 217

<A NAME="RG14106ST-15A">15a</A> Freedman LD. Doak GO. Chem. Rev. 1982, 82: 15

<A NAME="RG14106ST-15B">15b</A> Postel M. Dunãch E. Coord. Chem. Rev. 1996, 155: 127

<A NAME="RG14106ST-15C">15c</A> Suzuki H. Ikegami T. Matano Y. Synthesis 1997, 249

<A NAME="RG14106ST-15D">15d</A> Marshall JA. Chemtracts Org. Chem. 1997, 1064

<A NAME="RG14106ST-15E">15e</A> Le Roux C. Dubac J. Synlett 2002, 181

<A NAME="RG14106ST-15F">15f</A> Leonard NM. Wieland LC. Mohan RS. Tetrahedron 2002, 58: 8373

<A NAME="RG14106ST-15G">15g</A> Gaspard-Iloughmane H. Le Roux C. Eur. J. Org. Chem. 2004, 2517

<A NAME="RG14106ST-15H">15h</A> Mulamoottil VA. Synlett 2005, 2699

<A NAME="RG14106ST-16">16</A> Salvador JAR. Silvestre SM. Tetrahedron Lett. 2005, 46: 2581

<A NAME="RG14106ST-17">17</A> Yarovaya OI. Korchagina DV. Rybalova TV. Gatilov YV. Polovinka MP. Barkhash VA. Russ. J. Org. Chem. 2004, 40: 1593

<A NAME="RG14106ST-18">18</A> Caputo R. Ferreri C. Noviello S. Palumbo G. Synthesis 1986, 499

Selected Data.
Compound 2: ¹H NMR (300 MHz, CDCl₃): δ = 0.69 (3 H, s, 18-H₃), 1.12 (3 H, s, 19-H₃), 2.01 (3 H, s, CH₃COO), 2.02 (3 H, s, CH₃CONH), 4.02 (1 H, m, 6α-H), 5.16 (1 H, m, 3α-H), 5.60 (1 H, d, J = 9.7 Hz, NH). ¹³C NMR (75.5 MHz, CDCl₃): δ = 70.9 (C₃), 75.5 (C₅), 169.5 (CONH), 170.5 (COO). IR (ATR): 3394, 2934, 2870, 1734, 1716, 1662, 1514, 1374, 1245, 1029 cm^-1.
Compound 4: ¹H NMR (300 MHz, CDCl₃): δ = 0.90 (3 H, s, 18-H₃), 1.16 (3 H, s, 19-H₃), 2.02 (3 H, s, CH₃COO), 2.05 (3 H, s, CH₃CONH), 4.12 (1 H, m, 6α-H), 5.16 (1 H, m, 3α-H), 5.66 (1 H, d, J = 9.7 Hz, NH). ¹³C NMR (75.5 MHz, CDCl₃): δ = 70.6 (C₃), 75.4 (C₅), 169.6 (CONH), 170.5 (COO), 220.7 (C₁₇). IR (ATR): 3370, 2938, 2875, 1735, 1711, 1648, 1532, 1367, 1257, 1028 cm^-1.
Compound 6: ¹H NMR (300 MHz, CDCl₃): δ = 0.64 (3 H, s, 18-H₃), 1.12 (3 H, s, 19-H₃), 2.02 (3 H, s, CH₃COO), 2.02 (3 H, s, CH₃CONH), 2.12 (3 H, s, 21-H₃), 4.08 (1 H, m, 6α-H), 5.17 (1 H, m, 3α-H), 5.64 (1 H, d, J = 9.7 Hz, NH). ¹³C NMR (75.5 MHz, CDCl₃): δ = 70.8 (C₃), 75.4 (C₅), 169.6 (CONH), 170.6 (COO), 209.6 (C₂₀). IR (ATR): 3381, 2940, 2870, 1728, 1701, 1654, 1533, 1364, 1246, 1030 cm^-1. ES-MS: m/z (%) = 434 (100) [M]⁺, 416 (37), 374 (20), 356 (30). Anal. Calcd for C₂₅H₃₉NO₅: C, 69.25; H, 9.07; N, 3.23. Found: C, 69.01; H, 9.27; N, 3.38.
Compound 8: ¹H NMR (300 MHz, CDCl₃): δ = 0.68 (3 H, s, 18-H₃), 1.11 (3 H, s, 19-H₃), 2.00 (3 H, s, CH₃CONH), 3.98-4.19 (2 H, m, 3α-H and 6α-H), 5.69 (1 H, d, J = 10.1 Hz, NH). ¹³C NMR (75.5 MHz, CDCl₃): δ = 67.2 (C₃), 75.8 (C₅), 169.6 (CONH). IR (ATR): 3460, 3437, 2933, 2867, 1650, 1523, 1378, 1046 cm^-1.
Compound 10: ¹H NMR (300 MHz, CDCl₃): δ = 1.03 (3 H, s, 15-H₃), 2.00 (3 H, s, CH₃CONH), 3.29 (1 H, m, 9α-H), 4.14 (1 H, m, 2α-H), 5.54 (1 H, d, J = 9.2 Hz, NH). ¹³C NMR (75.5 MHz, CDCl₃): δ = 57.7 (C₂), 74.9 (C₉), 169.8 (CONH). IR (ATR): 3480, 3306, 2942, 2864, 1623, 1557, 1462, 1447, 1376, 1047 cm^-1.
Compound 11: ¹H NMR (300 MHz, CDCl₃): δ = 0.69 (3 H, s, 18-H₃), 1.27 (3 H, s, 19-H₃), 1.97 (3 H, s, CH₃COO), 4.27 (1 H, m, 6α-H), 5.18 (1 H, m, 3α-H), 6.28 (1 H, d, J = 9.7 Hz, NH), 7.44-7.58 (3 H, m, Ar), 7.72-7.78 (2 H, m, Ar). ¹³C NMR (75.5 MHz, CDCl₃): δ = 70.7 (C₃), 166.6 (CONH), 170.6 (COO). IR (ATR): 3463, 2936, 2862, 1729, 1717, 1654, 1575, 1516, 1477, 1364, 1240, 1030 cm^-1.
Compound 13: ¹H NMR (300 MHz, CDCl₃): δ = 0.90 (3 H, s, 18-H₃), 1.35 (3 H, s, 19-H₃), 2.01 (3 H, s, CH₃COO), 2.01 (3 H, s, CH₃CONH), 4.76 (1 H, m, 6α-H), 4.84 (1 H, m, 3α-H), 5.25 (1 H, s, NH). ¹³C NMR (75.5 MHz, CDCl₃): δ = 71.2 (C₃), 170.1 (CONH), 171.2 (COO), 221.3 (C₁₇). IR (ATR): 3451, 3407, 2941, 1735, 1721, 1658, 1507, 1375, 1239, 1026 cm^-1.
Compound 14: ¹H NMR (300 MHz, CDCl₃): δ = 0.70 (3 H, s, 18-H₃), 1.28 (3 H, s, 19-H₃), 2.04 (3 H, s, CH₃COO), 3.83 (1 H, m, 6α-H), 5.11 (1 H, m, 3α-H). ¹³C NMR (75.5 MHz, CDCl₃): δ = 64.0 (C₆), 71.1 (C₃), 76.4 (C₅), 171.0 (COO). IR (ATR): 3384, 2933, 1735, 1697, 1457, 1363, 1267, 1245, 1030, 687 cm^-1.

Ritter Reaction Mediated by Bismuth(III) Salts: One-Step Conversion of ­Epoxides into vic-Acylamino-Hydroxy Compounds

Ritter Reaction Mediated by Bismuth(III) Salts: One-Step Conversion of Epoxides into vic-Acylamino-Hydroxy Compounds